According to the World Health Organisation (WHO), no one can predict when the next influenza pandemic might occur.

However, biomedical experts agree that the occurrence of one is inevitable, and are watching the H5N1 (avian influenza A) situation in Europe and Asia very closely, for the possibility that the virus may begin to spread more easily and widely from person to person. In the US, the Department of Health and Human Services estimates that with a severe flu pandemic, 90 million Americans would become ill and nearly two million would die.

With this in mind, several recent announcements have been noteworthy in demonstrating how the filtration community has a vital role to play.

Cornell: Nanofibres filter research
===================================

To develop nanofibres potentially capable of filtering out viruses, bacteria and hazardous nanoparticles, Juan P. Hinestroza, assistant professor in the fibre science program (department of textiles and apparel) at Cornell, has won a James D. Watson Investigator Award for US\$200,000 -- over two years -- from the *New York State Office of Science, Technology and Academic Research*.

Hinestroza plans to develop a high-tech, nanoscale fibre spinning process capable of producing nanofibres for use in the high-performance filtration of contaminants, biological agents and hazardous (but very small) particles. It is hoped that such novel filtration systems will be capable of providing protection against hazardous substances such as toxic mould and infectious agents, including severe acute respiratory syndrome (SARS) and H5N1. A Pall breathing circuit filter in use

"We will look at the effect that functional nanofibres have on capturing biological samples and nanoparticles," Hinestroza told *Filtration + Separation* magazine. "We are producing nanofibres and coating them with functional groups that can detect and neutralise some specific biological threats. In addition, the nanofibres are intrinsically charged, and their electrostatic capturing capabilities are amplified due to the high radius of curvature of the nanofibre (50-90 nm.)"

As for the potential to take any of the research and use it in products as a potential pandemic advanced, he is keen to stress that at present the project is only at proof of concept stage, and he doesn\'t believe companies would be interested at this time. However, he is optimistic that this could change soon: "we expect to have some results that could attract investment by the summer. Cornell is one of the most efficient universities at commercialising technologies. Cornell, adds Hinestroza, will also continue to work with the US *Centers for Disease Control and Prevention (CDC)* through the *National Institute of Occupational Safety and Health*, which has "supported some of the basic work".

Products on the market
======================

In the event that the H5N1 strain does mutate and lead to a pandemic, personal protective equipment (in addition to hand hygiene) will become vital, especially for key health workers operating on the front line. For example in the USA, CDC recommends that health care workers who handle contagious patients -- including those infected by SARS and the avian flu -- wear masks that meet the n95 rating under the CDC\'s *National Institute for Occupational Safety and Health* \[this means that the respirators filter out at least 95 percent of airborne particles during testing using a "most-penetrating" sized particle of 0.3 microns.\] Vietnam, where owning birds is widespread, has been hit hard by the H5N1 avian flu strain, though experts stress that we aren\'t in a pandemic situation...yet.

One company that has already developed a nanomask -- designed to keep out biological hazards, including the Avian flu virus -- is US, Nevada-based **Emergency Filtration Products**. Speaking in an interview with US abc news, EFP\'s Doug Beplate claims that the nanomask can do better than the recommendations above, thanks to a coating that reacts to contaminants at the mask surface. He says that electric charges within the nanoparticle coating and among a contaminant react, rendering the contaminant inactive.

Demand for the product in the wake of spiralling H5N1 potential pandemic reports has reportedly lead to the company entering into distribution agreements with nine international distributors in Australia, Canada, Denmark, New Zealand, Pakistan, South Africa, South Korea, Sweden and Thailand. EFP also plans to open a second manufacturing facility in Nogales, Mexico, to cope with demand.

*\[NB: According to the same abc report, Beplate has not submitted his masks for CDC or NIOSH ratings because he wants to maintain intellectual privacy but he says an independent laboratory, Nelson Laboratories (US FDA registered), has tested the product and found it is 99.99 percent effective at filtering particles as small as 0.027 microns*.\]

**Pall Corp** points to the lessons learned from the SARS outbreak, where its breathing system filters (*see image below left*) were used internationally as a barrier between viral and bacterial transmission to patients, hospital staff and respiratory equipment. The filters for anaesthesia and respiratory care reportedly combine stringent requirements to provide an effective barrier against viral and bacterial contaminants, and were specifically recommended by international health authorities.

Pall says it has conducted extensive validation testing to show that its breathing system filters can be an effective barrier for bacterial and viral (air and liquid) routes of transmission. "Studies have shown that Pall\'s breathing system filters provide an effective barrier to contaminated liquids and have an airborne bacterial and viral removal efficiency of at least 99.999 percent," a source said. "The filters have been challenged with bacterial (Brevundimonas diminuta) and viral (MS-2 bacteriophage) organisms that represent the gold standard for pathogen exclusion on the basis of size."
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